Document ID: chunk:federal_register_of_legislation:F2024L00753:reg:9:p2
Version: federal_register_of_legislation:F2024L00753
Segment Type: reg
Provision Reference: reg 9 (pt 2/3)
Character Range: 6958–10207

period of at least 8 days, within the 3 months before clinical onset or clinical worsening;
(15)      having a solid organ or bone marrow transplant before clinical onset or clinical worsening;
(16)      being treated with an antineoplastic agent within the 3 months before clinical onset or clinical worsening;
Note: antineoplastic agent is defined in the Schedule 1 - Dictionary.
(17)      being treated with one of the following drugs or class of drugs within the 7 days before clinical onset or clinical worsening:
(a)          bisphosphonate, including alendronate;
(b)          chemotherapeutic agents delivered by hepatic arterial infusion; or
(c)          potassium chloride tablet (enteric coated or wax formulation);
(18)      being treated with one of the following drugs or class of drugs for at least 2 weeks, within the 3 months before clinical onset;
(a)          clopidogrel;
(b)          glucocorticoid, excluding topical or inhaled;
(c)          deferasirox;
(d)          nicorandil;
(e)          paracetamol of more than 2 grams daily; or
(f)           selective serotonin re-uptake inhibitors;
(19)      taking one of the following drugs or class of drugs for at least 2 weeks, within the 3 months before clinical worsening;
(a)          anticoagulants;
(b)          clopidogrel;
(c)          corticosteroids, excluding topical or inhaled;
(d)          lanthanum;
(e)          levodopa with benserazide or carbidopa;
(f)           methylnaltrexone;
(g)          nicotinic acid;
(h)          paracetamol of more than 2 grams daily;
(i)            pentoxifylline;
(j)            selective serotonin re-uptake inhibitors;
(k)          spironolactone;
(l)            tocilizumab;
(m)        tofacitinib; or
(n)          upadacitinib;
(20)      experiencing one of the following category 1A stressors within the 3 months before clinical onset or clinical worsening:
(a)          experiencing a life-threatening event;
(b)          being subject to a serious physical attack or assault including rape and sexual molestation; or
(c)          being threatened with a weapon, being held captive, being kidnapped, or being tortured.
(21)      having posttraumatic stress disorder within the 3 months before the clinical onset or clinical worsening;
(22)      being diagnosed by a registered medical practitioner with anxiety disorder, depressive disorder, bipolar disorder, obsessive compulsive disorder or panic disorder at the time of clinical onset or clinical worsening;
(23)      having cirrhosis of the liver at the time of clinical onset or clinical worsening;
(24)      having alcohol use disorder or drinking at least 4 standard drinks per day for at least 6 months at the time of bleeding of a gastric ulcer;
Note 1: The bleeding of a gastric ulcer is considered to be a clinical worsening.
Note 2: Alcohol consumption is calculated utilising the Australian Standard of 10 grams of alcohol per standard alcoholic drink.
(25)      having diabetes mellitus at the time of clinical onset or clinical worsening;
(26)      having Crohn disease (a type of inflammatory bowel disease) at the time of clinical onset or clinical worsening;
(27)      having one of the following medical conditions at the time of clinical onset or clinical